These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37296102)

  • 1. Empowering drug off-target discovery with metabolic and structural analysis.
    Chowdhury S; Zielinski DC; Dalldorf C; Rodrigues JV; Palsson BO; Shakhnovich EI
    Nat Commun; 2023 Jun; 14(1):3390. PubMed ID: 37296102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simultaneous detection of intracellular target and off-target binding of small molecule cancer drugs at nanomolar concentrations.
    Glauner H; Ruttekolk IR; Hansen K; Steemers B; Chung YD; Becker F; Hannus S; Brock R
    Br J Pharmacol; 2010 Jun; 160(4):958-70. PubMed ID: 20590591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of antibacterial compounds that constrain evolutionary pathways to resistance.
    Zhang Y; Chowdhury S; Rodrigues JV; Shakhnovich E
    Elife; 2021 Jul; 10():. PubMed ID: 34279221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baricitinib and tofacitinib off-target profile, with a focus on Alzheimer's disease.
    Faquetti ML; Slappendel L; Bigonne H; Grisoni F; Schneider P; Aichinger G; Schneider G; Sturla SJ; Burden AM
    Alzheimers Dement (N Y); 2024; 10(1):e12445. PubMed ID: 38528988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel phytochemical-antibiotic conjugates as multitarget inhibitors of Pseudomononas aeruginosa GyrB/ParE and DHFR.
    Jayaraman P; Sakharkar KR; Lim C; Siddiqi MI; Dhillon SK; Sakharkar MK
    Drug Des Devel Ther; 2013; 7():449-75. PubMed ID: 23818757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and prediction of the mechanism of action of antibiotics through NMR metabolomics.
    Hoerr V; Duggan GE; Zbytnuik L; Poon KK; Große C; Neugebauer U; Methling K; Löffler B; Vogel HJ
    BMC Microbiol; 2016 May; 16():82. PubMed ID: 27159970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative mapping of on-targets and off-targets for the discovery of anti-trypanosomatid folate pathway inhibitors.
    Panecka-Hofman J; Pöhner I; Spyrakis F; Zeppelin T; Di Pisa F; Dello Iacono L; Bonucci A; Quotadamo A; Venturelli A; Mangani S; Costi MP; Wade RC
    Biochim Biophys Acta Gen Subj; 2017 Dec; 1861(12):3215-3230. PubMed ID: 28939533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empowering the discovery of novel target-disease associations via machine learning approaches in the open targets platform.
    Han Y; Klinger K; Rajpal DK; Zhu C; Teeple E
    BMC Bioinformatics; 2022 Jun; 23(1):232. PubMed ID: 35710324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trade-offs with stability modulate innate and mutationally acquired drug resistance in bacterial dihydrofolate reductase enzymes.
    Matange N; Bodkhe S; Patel M; Shah P
    Biochem J; 2018 Jun; 475(12):2107-2125. PubMed ID: 29871875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning prediction of oncology drug targets based on protein and network properties.
    Dezső Z; Ceccarelli M
    BMC Bioinformatics; 2020 Mar; 21(1):104. PubMed ID: 32171238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unveiling the mechanism of action of nature-inspired anti-cancer compounds using a multi-omics approach.
    Soares NC; Ali A; Srinivasulu V; Sharaf BM; Giddey AD; Okendo J; Al-Hroub HM; Semreen MH; Hamad M; Al-Tel TH
    J Proteomics; 2022 Aug; 265():104660. PubMed ID: 35728772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linking High-Throughput Screens to Identify MoAs and Novel Inhibitors of Mycobacterium tuberculosis Dihydrofolate Reductase.
    Santa Maria JP; Park Y; Yang L; Murgolo N; Altman MD; Zuck P; Adam G; Chamberlin C; Saradjian P; Dandliker P; Boshoff HIM; Barry CE; Garlisi C; Olsen DB; Young K; Glick M; Nickbarg E; Kutchukian PS
    ACS Chem Biol; 2017 Sep; 12(9):2448-2456. PubMed ID: 28806050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of Resistance to Folate Pathway Inhibitors in
    Podnecky NL; Rhodes KA; Mima T; Drew HR; Chirakul S; Wuthiekanun V; Schupp JM; Sarovich DS; Currie BJ; Keim P; Schweizer HP
    mBio; 2017 Sep; 8(5):. PubMed ID: 28874476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolomics and modelling approaches for systems metabolic engineering.
    Khanijou JK; Kulyk H; Bergès C; Khoo LW; Ng P; Yeo HC; Helmy M; Bellvert F; Chew W; Selvarajoo K
    Metab Eng Commun; 2022 Dec; 15():e00209. PubMed ID: 36281261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
    Tomioka H
    Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco budworm dihydrofolate reductase is a promising target for insecticide discovery.
    Walker VK; Tyshenko MG; Kuiper MJ; Dargar RV; Yuhas DA; Cruickshank PA; Chaguturu R
    Eur J Biochem; 2000 Jan; 267(2):394-403. PubMed ID: 10632709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using machine learning approaches for multi-omics data analysis: A review.
    Reel PS; Reel S; Pearson E; Trucco E; Jefferson E
    Biotechnol Adv; 2021; 49():107739. PubMed ID: 33794304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges of target/compound data integration from disease to chemistry: a case study of dihydrofolate reductase inhibitors.
    Potts SJ; Edwards DJ; Hoffman R
    Curr Drug Discov Technol; 2005 Jun; 2(2):75-87. PubMed ID: 16472232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward Broad Spectrum Dihydrofolate Reductase Inhibitors Targeting Trimethoprim Resistant Enzymes Identified in Clinical Isolates of Methicillin Resistant
    Reeve SM; Si D; Krucinska J; Yan Y; Viswanathan K; Wang S; Holt GT; Frenkel MS; Ojewole AA; Estrada A; Agabiti SS; Alverson JB; Gibson ND; Priestley ND; Wiemer AJ; Donald BR; Wright DL
    ACS Infect Dis; 2019 Nov; 5(11):1896-1906. PubMed ID: 31565920
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.